Gurgaon Samachar

Keratoconus Market, Size, Share, Trends, Epidemiology Forecast till 2030

 Breaking News
  • No posts were found

Keratoconus Market, Size, Share, Trends, Epidemiology Forecast till 2030

September 08
16:39 2020
Keratoconus Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s ” Keratoconus Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Keratoconus is an eye disorder characterized by progressive thinning and changes in the shape of the cornea.

The initial Keratoconus treatment often consists of hard contact lenses. A variety of keratorefractive procedures have also been attempted, broadly divided into subtractive and additive techniques. Subtractive techniques include photorefractive keratectomy or laser in situ keratomileusis, although generally, the results of these techniques have been poor. Implantation of intrastromal corneal ring segments is an additive technique in which the implants are intended to reinforce the cornea, prevent further deterioration, and potentially obviate the need for penetrating keratoplasty. Penetrating keratoplasty (i.e., corneal grafting) is the last line of treatment.

The current Keratoconus treatment option includes Intrastromal corneal ring segments (ICRS), Corneal reshaping and Cross-Linking (CXL) along with Riboflavin solutions + UV Light, Keratoplasty and Others (Antihistamine/mast cell–stabilizing topical medications, antihistamines, mast cell stabilizers, nonsteroidal anti-inflammatory (NSAID), which provide the corneal clinicians a variety of treatment options for the visual rehabilitation of Keratoconus patients. In the mild forms of Keratoconus , eyeglasses or soft contact lenses are preferred, however, their market has been excluded from the forecast model.  

Keratoconus Market Insight

Keratoconus market size in 7MM in 2017 was USD 2,456 million 

Keratoconus Market Drivers

  • Emergence of New Diagnostic Techniques
  • Increasing Awareness of KC
  • Genetic Factors
  • Environmental Factors

Keratoconus Market Barriers

  • Fewer patients available for clinical trials
  • Lack of variety in treatment options

 

Request for sample pages
Table of contents

1. Key Insights

2. Executive Summary of Keratoconus

3. Competitive Intelligence Analysis for Keratoconus

4. Keratoconus: Market Overview at a Glance

4.1. Keratoconus Total Market Share (%) Distribution in 2017

4.2. Keratoconus Total Market Share (%) Distribution in 2030

5. Keratoconus: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Keratoconus Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Keratoconus Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Keratoconus Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Keratoconus Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Keratoconus Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Keratoconus Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Keratoconus Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Keratoconus Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Keratoconus Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Keratoconus Treatment and Management

8.2. Keratoconus Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Keratoconus Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Keratoconus: Seven Major Market Analysis

13.1. Key Findings

13.2. Keratoconus Market Size in 7MM

13.3. Keratoconus Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Keratoconus Total Market Size in the United States

15.1.2. Keratoconus Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Keratoconus Total Market Size in Germany

15.3.2. Keratoconus Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Keratoconus Total Market Size in France

15.4.2. Keratoconus Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Keratoconus Total Market Size in Italy

15.5.2. Keratoconus Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Keratoconus Total Market Size in Spain

15.6.2. Keratoconus Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Keratoconus Total Market Size in the United Kingdom

15.7.2. Keratoconus Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Keratoconus Total Market Size in Japan

15.8.3. Keratoconus Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Keratoconus

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: DelveInsight
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Recent Posts

Acute-on-Chronic Liver Failure Market to Witness Growth by 2032, Estimates DelveInsight | Grifols Therapeutics, Versantis AG, HepaStem

Read Full Article

Categories